Bringing the fundamentals into focus…
Back to Revvity, Inc.
How Revvity, Inc. stacks up
RVTY · against 454 other Healthcare companies listed in US-listed
Growth
29/ 100
Near the bottom of its peers.
Ranked #352 of 455 · scores higher than 22% of peers
Bars: peers in each 10-point band of the growth score34 peers with a growth score of 20–29, including RVTY · Click a bar to see the companies
Why growth scores 29?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 81% of peers. 3-year revenue growth: -4.8% vs peer median 5.8%
- slower growth in earnings per share: weaker than 67% of peers. Earnings per share growth: -5.9% vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 3.7% vs peer median 6.1%
Metric by metric
Position: dot = RVTY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RVTY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 3.7% | 11.0% | 30% | 33% | |
| Earnings per share growthHigher is better · 171 reported | -5.9% | 21.2% | 25% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | -4.8% | 11.0% | 13% | 33% |
Ranking by growth score
Top 5 and the companies ranked around RVTY| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 352 | 1.3B USD | 29 | 15 | |
| 352 | 318M USD |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score